Cargando…

487 Safety of Sublingual Immunotherapy with Standardized Vaccines of Domestic Mites

BACKGROUND: Allergen-specific immunotherapy consists of administering gradually increasing doses of the allergen, to which the patient is sensitized, aiming at achieving tolerance to it and decreasing clinical symptoms. The sublingual immunotherapy (SLIT) was introduced as an alternative to subcutan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alvarez, Mirta, Castro, Raúl, Gutierrez, Daniel, Labrada, Alexis, Enriquez, Irene, Ronquillo, Mercedes, Rodríguez, José, García, Iris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization Journal 2012
Materias:	Abstracts of the XXII World Allergy Congress
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512939/ http://dx.doi.org/10.1097/01.WOX.0000411602.04691.30

Ejemplares similares

159 Therapeutic Effect and Safety of the Sublingual Immunotherapy With Tropical House Dust Mite Allergen Vaccines in Asthmatic Cuban Adult Patients
por: Castro Almarales, Raúl Lázaro, et al.
Publicado: (2012)

486 Therapeutic Effect and Security in Asthmatics Adult Patients Treated with Dermatophagoides Pteronyssinus Allergen Sublingual Immunotherapy
por: Rodríguez, José, et al.
Publicado: (2012)

485 Therapeutic Effect and Safety of Tropical Mite Allergen Vaccines by Subcutaneous Route in Allergic Asthmatics Patients
por: Castro Almarales, Raúl Lázaro, et al.
Publicado: (2012)

200 Efficacy of Mite Sublingual Immunotherapy in 130 Children with Atopic Dermatitis
por: Tang, Jianping
Publicado: (2012)

204 IGE/IGG4 Ratio as a Possible Surrogate Marker of Clinical Efficacy During Allergen-Specific Immunotherapy with House Dust Mite Vaccines
por: Labrada, Alexis, et al.
Publicado: (2012)

157 The Post-Treatment Efficacy of House Dust Mite Sublingual Allergen Immunotherapy Tablets in Adults With Allergic Rhinitis
por: Bergmann, Karl-Christian, et al.
Publicado: (2012)

489 Does Sublingual Immunotherapy Work with an Immune Deviation Mechanism?
por: Sensi, Laura Giovanna, et al.
Publicado: (2012)

201 Clinical Efficacy and Mucosal/Systemic Antibody Response Changes After Sublingual Immunotherapy in Mite-Allergic Children: A Randomized Double-Blind, Placebo-Controlled Study in Brazil
por: Queirós, Meimei, et al.
Publicado: (2012)

202 Treatment Satisfaction with Sublingual Immunotherapy in a Real-Life Setting
por: Hadler, Meike, et al.
Publicado: (2012)

212 Allergic Sensitization to Domestic Mites in Santo Domingo, Dominican Republic
por: Castillo, Antonio, et al.
Publicado: (2012)

60 Tear IFN-G is Increased After Sublingual Immunotherapy in Allergic Conjunctivitis Patients and Correlates With Clinical Improvement
por: Aguilar-Velazquez, Gustavo, et al.
Publicado: (2012)

378 Aspirin Desensitization Treatment: A Case Report
por: Alvarez, Mirta, et al.
Publicado: (2012)

3 Double-blind Study of the Use of Transfer Factor (TF) Combined With Sublingual Immunotherapy in Management of Patients With Allergic Rhinitis in Mexican Population
por: Rojo Gutiérrez, María Isabel, et al.
Publicado: (2012)

176 Sublingual Immunotherapy for Grass Pollen Allergy in Children: A Systematic Review and Meta-Analysis
por: Bryson, Rebecca
Publicado: (2012)

397 Standardization and Characterization of Dust Mite Extracts Manufactured in the USA
por: Plunkett, Greg
Publicado: (2012)

160 Candidate for Response Monitoring or Prognostic Biomarkers in Two-Year Sublingual Immunotherapy for Japanese Cedar Pollinosis
por: Fujimura, Takashi, et al.
Publicado: (2012)

161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
por: Cox, Linda, et al.
Publicado: (2012)

162 Establishing the Effectiveness, Cost-Effectiveness and Safety of Oral and Sublingual Immunotherapy for Food Allergy: A Systematic Review and Meta-Analysis of Intervention Studies
por: Nurmatov, Ulugbek, et al.
Publicado: (2012)

402 Oral Mite Anaphylaxis is Caused by Mite-contaminated Okonomiyaki Mix in Japan
por: Takahashi, Kentaro, et al.
Publicado: (2012)

226 Analysis of an After-Care Questionnaire in Allergic People to Dust Mites Using Anti-Dust Mites Bed Covers
por: Boukhettala, Nabile, et al.
Publicado: (2012)

466 Bee venom Immunotherapy with Standardized Extract, Two Case Comunication and Clinical Progress
por: Cardona, Aristoteles Alvarez, et al.
Publicado: (2012)

106 Neisseria Meningitidis Derived Proteoliposome as an Adjuvant for Allergen Vaccines
por: González, Wendy Ramírez, et al.
Publicado: (2012)

266 First Report of Anaphylactic Shock Caused by the Ingestion of Mite-Infested Flour in Panama
por: Barrera de Pino, Olga Melcina, et al.
Publicado: (2012)

14 Comprehensive Expression of Recombinant House Dust Mite Allergens for Component-Resolved Diagnosis
por: Watakabe, Yoshiharu, et al.
Publicado: (2012)

398 Detection of DER P 2 in the House Dust and Correlation with Mite Number in an Environmental Survey
por: Tsai, Jaw-Ji, et al.
Publicado: (2012)

401 House Dust Mite Fauna and Its Relationship to Allergen Skin Tests in Six Mexican States
por: Ferández Duro, Bárbara Isabel, et al.
Publicado: (2012)

111 Taxonomic Identification of the House Dust Mites Associated to Allergic Patients in 6 Locations From Mexico
por: Cuervo, Naomi, et al.
Publicado: (2012)

5 Posttreatment, Long-Term Clinical Efficacy of a 300 IR Sublingual Tablet of 5-Grass Pollen Allergen Extract in Adults With Grass Pollen Induced Allergic Rhinoconjunctivitis
por: Didier, Alain, et al.
Publicado: (2012)

399 Daily Vacuum Cleaning Significantly Reduces House Dust Mite Allergen, Endotoxin and β-glucan Content of Mattresses
por: Fu-Sheng Wu, Francis, et al.
Publicado: (2012)

419 IGE-mediated Responses Towards Fish Parasite Anisakis, Crab and House Dust Mite in Norwegian Shrimp Allergic Individuals
por: Dooper, Maaike, et al.
Publicado: (2012)

208 Compliance and Persistence to Grass Immunotherapy Treatment is Comparable for Allergy Immunotherapy Tablets and Subcutaneous Immunotherapy: A Swedish Registry Study
por: Andreasen, Jakob Nørgaard, et al.
Publicado: (2012)

490 Immunotherapy (IT) Training in Canada: Perspectives of Fellows-in-training on the First Immunotherapy Training Manual
por: Pun, Teresa, et al.
Publicado: (2012)

41 S100A8/A9, a Damp Molecule Activated by IL-17 and House Dust Mite is Upregulated in Atopic Dermatitis
por: Jin, Shan, et al.
Publicado: (2012)

198 AAAAI Survey on Immunotherapy Practice Patterns Concerning Dosing, Dose-Adjustment after Missed Doses and Duration of Immunotherapy
por: Linnemann, Désirée Larenas, et al.
Publicado: (2012)

4 The Risk of Severe Treatment Related Adverse Events is Significantly Lower in Children Compared to Adults When Treated With Standardized Timothy Grass Allergy Immunotherapy Tablets: Post Hoc Analysis of 7 Clinical Trials
por: Andersen, Jens Strodl, et al.
Publicado: (2012)

75 Efficacy of Slow Oral Immunotherapy for Cow's Milk Allergy
por: Ogura, Kiyotake, et al.
Publicado: (2012)

199 Development of a National Guideline on Skin Testing and Immunotherapy
por: Linnemann, Désirée Larenas, et al.
Publicado: (2012)

404 Allergen Specific Immunotherapy as a Treatment for Eosinophilic Esophagitis
por: Perez, Juan Esteban, et al.
Publicado: (2012)

11 Efficacy and Tolerability of HDM Injective Immunotherapy With Monomeric Allergoid
por: Compalati, Enrico, et al.
Publicado: (2012)

491 Immunotherapy (IT) Training in Canada: Current Experience of Fellows-in-training
por: Pun, Teresa, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n3j924te70bctd06vda5crqsv0